Healthcare
We create and invest in leading companies in therapeutics, medtech, and health IT & services.
Thirty three products and drugs approved
With another 12 drugs in phase 3. Typically, only 1 in 5,000 drugs makes it from idea to market.
Over thirty companies created from scratch
If we can't find a company solving an important problem, we create one ourselves - just like we did with Innovent, Denali, Beam and Prime Medicine to name a few.
Over three and a half billion dollars over eleven funds
Without the pressure of fundraising from outside investors, we're privileged to champion companies that help heal the world.
Category
-
EQS News
Eckert & Ziegler and ARTBIO Announce Manufacturing and Supply Partnership for Lead-212 Conjugates
January 8, 2024 -
PR Newswire
OnCusp Therapeutics Raises Oversubscribed $100 Million Series A Financing to Advance Portfolio of Assets for Cancer Patients
January 4, 2024 -
Fierce Healthcare
Devoted Health closes out 2023 with $175M series E funding round
January 1, 2024 -
Fierce Healthcare
VA deepens partnership with AppliedVR to expand access to immersive therapeutics
December 20, 2023 -
PR Newswire
Veterans Health Administration Extends Contract with AppliedVR to Continue Use of Virtual Reality for Treating Chronic Low Back Pain
December 20, 2023 -
Economic Times India
PlasmaGen Biosciences raises Rs 225 crore in equity funding
December 14, 2023 -
PR Newswire
WelbeHealth Opens First Bay Area PACE Center Serving Vulnerable Seniors in San Jose
December 12, 2023 -
PR Newswire
Fortune Announces the 2023 ‘Impact 20’ Startups That Are Making a Difference
December 12, 2023 -
Business Wire
Bicara Therapeutics Announces Oversubscribed $165 Million Series C Financing
December 12, 2023 -
Endpoints News
Exclusive: Shinobi raises $51M to take on cell therapy challenges with ex-Wugen CEO at helm, Carl June in support
December 12, 2023 -
Endpoints News
Biocon oncology spinout Bicara secures its second nine-figure financing of the year
December 12, 2023 -
Endpoints News
ARTBIO raises $90M as radiopharma field finds its footing
December 7, 2023 -
PR Newswire
ABK Biomedical announces that its Eye90 microspheres® device has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA)
December 5, 2023 -
PR Newswire
Insilico Medicine Announces First-in-Human Study for Orally PHD Inhibitor ISM5411 for Inflammatory Bowel Disease (IBD)
December 5, 2023 -
Oviva
A milestone in the digital health revolution: Doctors prescribe app-based obesity and diabetes care to 500,000th patient
December 4, 2023 -
PR Newswire
K36 Therapeutics Announces Presentation on KTX-1001 for Relapsed and Refractory Multiple Myeloma at the 65th American Society of Hematology (ASH) Annual Meeting
December 4, 2023 -
PR Newswire
AmplifyMD Named a Winner in Fast Company’s Next Big Things in Tech
November 30, 2023 -
PR Newswire
Eleos Health and Kipu Health Announce Partnership to Deliver AI-Powered Insights to Behavioral Health Providers
November 28, 2023 -
PR Newswire
K36 Therapeutics Announces Appointment of Benjamin Winograd, MD, PhD, as Chief Medical Officer
November 15, 2023 -
The Standard
London doctors become first in the UK to ‘livestream’ surgery using robot
November 15, 2023 -
Financial Times
Biotech raises funds to find cancer treatments using transgenic mice
November 15, 2023 -
Globenewswire
T-Therapeutics raises £48 million Series A for development of next generation TCR therapeutics to transform cancer treatment
November 15, 2023 -
PR Newswire
Capital Rx and Vida Health Partner to Launch Rx Activate, a High-Touch Chronic Condition Management Program
November 14, 2023 -
PR Newswire
NFlection Therapeutics Announces Positive Results from Phase 2b Study of NFX‑179 Topical Gel in the Treatment of Cutaneous Neurofibromas in Neurofibromatosis Type 1
November 13, 2023 -
PR Newswire
Behavioral Health AI Leader Eleos Health Raises $40M Series B Round to Expand CareOps Automation Footprint
November 8, 2023 -
Endpoints News
AppliedVR is betting a new study could strengthen the case for insurance coverage of its VR chronic pain treatment
November 7, 2023 -
PR Newswire
OWKIN Integrates 10x Genomics Spatial Omics and Single-Cell Technologies to the MOSAIC Study
November 6, 2023 -
Business Wire
AviadoBio Announces FDA IND Clearance and Fast Track Designation for AVB-101 for the Treatment of Frontotemporal Dementia with Progranulin (GRN) Mutations
November 6, 2023 -
Endpoints News
Prime Medicine showcases its first in vivo editing data in monkeys and mice
October 30, 2023 -
Boston Business Journal
FDA lifts clinical hold on LDL-lowering drug from Verve Therapeutics
October 23, 2023 -
GlobeNewswire
NodThera announces first patients dosed in a Phase Ib/IIa cardiovascular risk trial of NLRP3 inflammasome inhibitor NT-0796
October 16, 2023 -
Business Wire
AviadoBio Announces Initiation of Phase 1/2 Clinical Trial, ASPIRE-FTD, Evaluating AVB-101 in People with Frontotemporal Dementia with GRN Mutations
October 10, 2023 -
PR Newswire
Rippl and McLean Hospital collaborate to build ‘first of its kind’ dementia training program
October 9, 2023 -
PR Newswire
Paradigm and Bristol Myers Squibb collaborate to build a new model for clinical trials
October 6, 2023 -
Globenewswire
Kyowa Kirin to Acquire Orchard Therapeutics
October 5, 2023 -
Business Wire
Aerium Therapeutics Advances Next Generation Antibodies to Protect Immunocompromised Persons Against COVID-19
October 4, 2023 -
Globenewswire
Structure Therapeutics Announces Positive Results from Phase 1b Clinical Study of Oral GLP-1 Receptor Agonist GSBR-1290 and Provides Program Update
September 29, 2023 -
PR Newswire
Doceree raises $35 million in Series B funding, led by Creaegis with participation from Eight Roads Ventures and F-Prime Capital
September 27, 2023 -
Endpoints News
Avalyn raises $175M to test inhaler versions of IPF medicines in PhII trials
September 27, 2023 -
Globenewswire
Avalyn Raises $175 Million in Oversubscribed Series C Financing to Advance Inhaled Pulmonary Fibrosis Programs into Later Stage Clinical Studies
September 27, 2023 -
Endpoints News
Labcorp backs Adela’s $48M Series A1 to advance methylation-based head and neck cancer test
September 25, 2023 -
Wall Street Journal
All Pregnant Women Should Be Screened for Blood-Pressure Disorders, U.S. Advisers Say
September 19, 2023 -
Fierce Healthcare
Equip nabs additional investment to expand virtual eating disorder treatment services to adult patients
September 19, 2023 -
Globenewswire
Neumora Therapeutics Announces Pricing of Initial Public Offering
September 14, 2023 -
Newswire
Owkin and Tribun Health Launch Strategic Partnership to Accelerate Access to AI Solutions for Diagnosis and Pharma Research
September 11, 2023 -
Globenewswire
Beam Therapeutics Announces First Patient Dosed in Phase 1/2 Trial of BEAM-201 in Relapsed, Refractory T-ALL/T-LL
September 5, 2023 -
Eleos Health
Eleos Health and KCare Join Forces to Improve Clinician Support with CareOps Automation
August 31, 2023 -
Boston Business Journal
Substance-use treatment startup Better Life Partners completes $26.5M Series B fundraise
August 29, 2023 -
PR Newswire
Comanche Biopharma Named by Fierce Biotech as a “Fierce 15” Biotech Company of 2023
August 28, 2023 -
PR Newswire
Comanche Biopharma Receives US FDA Fast Track Designation for CBP-4888 for the Treatment of sFlt-1 mediated pre-term preeclampsia
August 23, 2023 -
Boston Business Journal
Firefly grows in wake of healthcare disruptions in southeastern Mass.
August 22, 2023 -
Business Wire
Madaket Health Releases Provider Data Exchange to Help Payers Remain Compliant with the No Surprises Act
August 17, 2023 -
PR Newswire
TraceLink Collaborates with GS1 US to Author GS1 US Addendum Guidance and XML Examples for GS1 US DSCSA Implementation Guideline R1.3 to Support EPCIS Data Exchange
August 16, 2023 -
PR Newswire
Innovent Announces the NMPA Approval of SINTBILO® (Tafolecimab Injection) for the Treatment of Adult Patients with Primary Hypercholesterolemia and Mixed Dyslipidemia
August 16, 2023 -
BioPharma Dive
Radiopharmaceuticals for cancer: Making radiation precise
August 15, 2023 -
Business Wire
Health Plan Alliance Selects 1upHealth as Preferred Health Data Interoperability Partner
August 15, 2023 -
PR Newswire
Memorial Hermann Health System Makes a Strategic Investment in Capital Rx Customer Solutions Platform
August 10, 2023 -
Gulf Business
SoftBank-backed Proximie launches virtual robotic-assisted surgery training course
August 10, 2023 -
PR Newswire
Talkiatry and NOCD Team up to Strengthen OCD Care Journeys
August 8, 2023 -
Behavioral Health Business
Better Life Partners Lands $26.5M for Virtual SUD, Mental Health Platform
August 7, 2023 -
Globenewswire
Avalyn Pharma Expands Executive Team with Appointment of Howard M. Lazarus, MD, FCCP to the Role of Chief Medical Officer
August 7, 2023 -
MedCity News
Talkiatry, NOCD Strike Partnership To Support Patients With OCD
August 7, 2023 -
Endpoints News
Born out of Omega push for pandemic treatments, Aerium Therapeutics enters long Covid R&D
August 4, 2023 -
Owkin
With ISO certification, Owkin demonstrates commitment to utmost quality with its AI solutions for digital pathology
August 3, 2023 -
PR Newswire
Sironax Announces Closing of $200 Million Series B Financing
August 2, 2023 -
National Venture Capital Association
Member Spotlight: F-Prime Capital
July 27, 2023 -
Globenewswire
Avalyn Pharma Invited to Present at Canaccord Genuity Annual Growth Conference
July 27, 2023 -
PRWeb
Patina teams with Humana to expand reach of convenient, relationship-centered primary care for people with Medicare
July 26, 2023 -
Fierce Healthcare
VR helps brain tumor patients overcome “scanxiety” before brain scans, study finds
July 24, 2023 -
Business Wire
Bicara Therapeutics Expands Management Team with the Appointment of David Raben, M.D., as Chief Medical Officer
July 24, 2023 -
PR Newswire
AppliedVR and National Cancer Institute Collaborate on Research Evaluating Virtual Reality for Reducing Anxiety in Primary Brain Tumor Patients During Imaging Services
July 20, 2023 -
EIN Presswire
Centivo Launches Partnership with SSM Health
July 14, 2023 -
Endpoints News
Tenpoint Therapeutics launches with $70M to restore vision with stem cell therapies and ‘reprogramming’ medicines
July 12, 2023 -
Globenewswire
NodThera is first to demonstrate reduction in neuroinflammation in the clinic with brain penetrant NLRP3 inflammasome inhibitor
July 11, 2023 -
PR Newswire
Zus Health Joins Civitas Networks for Health
July 10, 2023 -
PRWeb
Patina brings innovative primary care for people 65+ to Charlotte region; designed to help individuals thrive & remain independent
July 7, 2023 -
BioSpace
Ultragenyx Announces First Patients Dosed in Phase 3 Program Evaluating Setrusumab (UX143) for the Treatment of Osteogenesis Imperfecta (OI)
July 6, 2023 -
PR Newswire
Centivo Launches Partnership with SSM Health in the Fond du Lac Market to Offer Wisconsin Businesses and Employees More Affordable, High-Quality Healthcare
July 6, 2023 -
PR Newswire
China NMPA approves RareStone’s pitolisant (Wakix) for the treatment of narcolepsy
July 4, 2023 -
BioSpace
Skyline Therapeutics Receives FDA Clearance of IND for SKG0106, a Novel Intravitreally Delivered AAV Gene Therapy Candidate for Neovascular Age-related Macular Degeneration
July 3, 2023 -
PR Newswire
Innovent and IASO Bio Announce the NMPA Approval of FUCASO®, the First Fully-human BCMA CAR-T Therapy, for the Treatment of Relapsed or Refractory Multiple Myeloma
July 2, 2023 -
BioPharma Dive
F-Prime’s Ketan Patel on ‘reverse ageism’ in biotech and investing in a downturn
June 30, 2023 -
Endpoints News
K36 Therapeutics raises $70M in Series B to fund multiple myeloma research
June 29, 2023 -
PR Newswire
K36 Therapeutics Announces $70 Million Series B Financing to Fund Clinical Proof of Concept of KTX-1001, First-in-class Inhibitor of MMSET for Treatment of Multiple Myeloma Patients with Genetic Translocation (4;14)
June 28, 2023 -
Fierce Healthcare
Menopause care is still a largely untapped market. Here’s why investors and startups should dive in
June 28, 2023 -
Fox News
First AI-generated drug enters human clinical trials, targeting chronic lung disease patients
June 28, 2023 -
Financial Times
Biotech begins human trials of drug designed by artificial intelligence
June 27, 2023 -
PR Newswire
First Drug Discovered and Designed with Generative AI Enters Phase II Trials, with First Patients Dosed
June 27, 2023 -
LabPulse
Harvard Medical School, RareCyte developing multiplex imaging for clinical pathology
June 26, 2023 -
Business Wire
Invetx Appoints Dr. Marcus Remmers, Novo Holdings Partner and Animal Health Industry Leader, to Board of Directors
June 26, 2023
The list includes investments made by funds managed by F-Prime. The companies are listed in alphabetical order. The list of investments is updated quarterly and, as such, may not reflect most recent F-Prime investments. This list also excludes companies that are currently in stealth.